Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Write the correct units on a sticky note and put it on your fridge next to the vial
Taking into account the above-mentioned considerations on cost and safety aspects, oral small molecule agonists stimulating endogenous GLP-1 secretion by intestinal L-cells may offer a promising alternative for developing new treatments for Type 2 diabetes and obesity
Always consult a healthcare professional for any adjustments or specific questions related to dosing
This means that the drug targets not one, but two unique incretin hormones produced by the human bodywhich has been shown to increase the efficacy of the drug compared to medications that target only GLP-1
Some patients experience constipation, which could theoretically increase intra-colonic pressure and potentially trigger diverticulitis symptoms, though there is no established clinical evidence directly linking these medications to diverticulitis flare-ups
